Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 8 → 9·14:21, 28 May 2025
Difference between revision 8 and revision 9 of Xi'an Mokemei Biotechnology. 8 lines changed; the page grew by 536 bytes.
| Revision 8 — 05:10, 14 May 2025 CheckSumChase (talk) add the reception tally with its period and count stated 5,251 bytes +159 | Revision 9 — 14:21, 28 May 2025 BPC_Bramwell (talk) rm the discount code added by an anonymous editor 5,787 bytes +536 | ||
|---|---|---|---|
| 32 | Supplementary documentation — a residual-solvent screen, a second certificate covering an earlier lot, the analytical conditions behind a figure — is issued on request from the organisation's own records, and submissions describing such requests report them met within a working day.{{r|reports}} | 32 | Supplementary documentation — a residual-solvent screen, a second certificate covering an earlier lot, the analytical conditions behind a figure — is issued on request from the organisation's own records, and submissions describing such requests report them met within a working day.{{r|reports}} |
| 33 | 33 | ||
| + | 34 | == Product range == | |
| + | 35 | | Class | Representative listings | Documentation reported | | |
| + | 36 | |---|---|---| | |
| + | 37 | | Incretin analogues | Semaglutide, tirzepatide | Certificate with purity and appearance; water on request | | |
| + | 38 | | Research peptides | Repair and secretagogue peptides | Certificate with purity; water on request | | |
| + | 39 | | Extract-derived materials | Botanical extracts, standardised | Certificate with marker-compound assay; assay basis stated on request | | |
| + | 40 | | SARMs and raw materials | Bulk | Certificate with purity; specification sheet on request | | |
| + | 41 | ||
| 34 | == References == | 42 | == References == |
| 35 | {{reflist}} | 43 | {{reflist}} |